Neuralstem

Critical new piece on MD Stem Cells purported Right To Try program: let’s dig into it

Steven-Levy-Jeffrey-Weiss

I’ve been concerned about a stem cell group called MD Stem Cells for many years. Now it comes under more scrutiny from a new must-read piece by Donna Young over at S&P Global. Young’s article reports a puzzling, purported right-to-try (RTT) program that MD Stem Cells appears to working on with Richard Garr. Note that …

Critical new piece on MD Stem Cells purported Right To Try program: let’s dig into it Read More »

Richard Garr Q&A on his new Right-To-Try firm Beacon of Hope

NSRichard08-headshot

A new right-to-try company called Beacon of Hope is stirring some intense discussion. State and federal right-to-try laws could potentially change the fabric of how many investigational studies are conducted. That may happen through firms like Beacon of Hope. However, we don’t know much about the firm. I’m hoping to help change that. Today’s post …

Richard Garr Q&A on his new Right-To-Try firm Beacon of Hope Read More »

Stem Cell Person of the Year 2016: Patient Advocate Ted Harada

Stem-cell-ethics-meeting-e1479769073498

Patient advocate Ted Harada is the recipient of this year’s Stem Cell Person of the Year Award. Congrats also to the runner-up, HD patient advocate Judy Roberson. The three of us together are pictured at left. You can read about the 20 nominees here and see the vote results that picked the 10 finalists here. …

Stem Cell Person of the Year 2016: Patient Advocate Ted Harada Read More »

Tribute to Ted Harada, pioneering stem cell trial participant and ALS advocate

Harada-Family-e1479769086296

It takes a great deal of courage to participate in a clinical trial, patients who make that choice are heroes in my book and one such hero with stem cells was Ted Harada who had ALS. Sadly, Ted passed away from a brain tumor called glioblastoma last month. When enrolling in a trial, you just never …

Tribute to Ted Harada, pioneering stem cell trial participant and ALS advocate Read More »

Interview with Neuralstem CEO Richard Garr

I invited Neuralstem CEO, Richard Garr, to do a Q&A interview and he kindly accepted. The interview provides some novel insights into this major biotech in the stem cell sector. 1. How is Neuralstem doing today? What programs are underway that you find particularly exciting?  Garr: Neuralstem is moving on all cylinders these days on …

Interview with Neuralstem CEO Richard Garr Read More »

Interview with StemCells Inc. leadership on hot topics

GregSchiffman

StemCells Inc. is a top biotech company developing stem cell-based therapies. They have a deep pipeline that includes already ongoing trials for a variety of diseases. I invited company leadership to do an interview and they graciously accepted. Below is the interview with CFO Greg Schiffman (picture at left from LinkedIn) including what I thought …

Interview with StemCells Inc. leadership on hot topics Read More »

Interview with Ted Harada Part 2: Right To Try, Neuralstem, and How He’s Doing

Harada-Family-e1479769086296

This is Part 2 of my interview with ALS and stem cell advocate, Ted Harada. You can read Part 1 of my talk with Ted on where things stand today with ALS, the FDA, and the Ice Bucket Challenge. What’s your opinion of the “Right To Try” law in Colorado and the concept more generally? …

Interview with Ted Harada Part 2: Right To Try, Neuralstem, and How He’s Doing Read More »